List of Tables
Table 1. Global Primary Immunodeficiency Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoglobulin Replacement Therapy
Table 3. Key Players of Stem Cell or Bone Marrow Transplantation
Table 4. Key Players of Antibiotic Therapy
Table 5. Key Players of Gene Therapy
Table 6. Key Players of Others
Table 7. Global Primary Immunodeficiency Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Primary Immunodeficiency Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Primary Immunodeficiency Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Primary Immunodeficiency Therapeutic Market Share by Region (2020-2025)
Table 11. Global Primary Immunodeficiency Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Primary Immunodeficiency Therapeutic Market Share by Region (2026-2031)
Table 13. Primary Immunodeficiency Therapeutic Market Trends
Table 14. Primary Immunodeficiency Therapeutic Market Drivers
Table 15. Primary Immunodeficiency Therapeutic Market Challenges
Table 16. Primary Immunodeficiency Therapeutic Market Restraints
Table 17. Global Primary Immunodeficiency Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Primary Immunodeficiency Therapeutic Market Share by Players (2020-2025)
Table 19. Global Top Primary Immunodeficiency Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Immunodeficiency Therapeutic as of 2024)
Table 20. Ranking of Global Top Primary Immunodeficiency Therapeutic Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Primary Immunodeficiency Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Primary Immunodeficiency Therapeutic, Headquarters and Area Served
Table 23. Global Key Players of Primary Immunodeficiency Therapeutic, Product and Application
Table 24. Global Key Players of Primary Immunodeficiency Therapeutic, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Primary Immunodeficiency Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Primary Immunodeficiency Therapeutic Revenue Market Share by Type (2020-2025)
Table 28. Global Primary Immunodeficiency Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Primary Immunodeficiency Therapeutic Revenue Market Share by Type (2026-2031)
Table 30. Global Primary Immunodeficiency Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Primary Immunodeficiency Therapeutic Revenue Market Share by Application (2020-2025)
Table 32. Global Primary Immunodeficiency Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Primary Immunodeficiency Therapeutic Revenue Market Share by Application (2026-2031)
Table 34. North America Primary Immunodeficiency Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Primary Immunodeficiency Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Primary Immunodeficiency Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Primary Immunodeficiency Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Primary Immunodeficiency Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Primary Immunodeficiency Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Primary Immunodeficiency Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Primary Immunodeficiency Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Primary Immunodeficiency Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Primary Immunodeficiency Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Primary Immunodeficiency Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Primary Immunodeficiency Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 49. Baxter International Company Details
Table 50. Baxter International Business Overview
Table 51. Baxter International Primary Immunodeficiency Therapeutic Product
Table 52. Baxter International Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 53. Baxter International Recent Development
Table 54. Takeda Pharmaceutical Company Details
Table 55. Takeda Pharmaceutical Business Overview
Table 56. Takeda Pharmaceutical Primary Immunodeficiency Therapeutic Product
Table 57. Takeda Pharmaceutical Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 58. Takeda Pharmaceutical Recent Development
Table 59. CSL Limited Company Details
Table 60. CSL Limited Business Overview
Table 61. CSL Limited Primary Immunodeficiency Therapeutic Product
Table 62. CSL Limited Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 63. CSL Limited Recent Development
Table 64. Octapharma Company Details
Table 65. Octapharma Business Overview
Table 66. Octapharma Primary Immunodeficiency Therapeutic Product
Table 67. Octapharma Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 68. Octapharma Recent Development
Table 69. Kedrion Biopharma Company Details
Table 70. Kedrion Biopharma Business Overview
Table 71. Kedrion Biopharma Primary Immunodeficiency Therapeutic Product
Table 72. Kedrion Biopharma Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 73. Kedrion Biopharma Recent Development
Table 74. Bio Products Laboratory Company Details
Table 75. Bio Products Laboratory Business Overview
Table 76. Bio Products Laboratory Primary Immunodeficiency Therapeutic Product
Table 77. Bio Products Laboratory Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 78. Bio Products Laboratory Recent Development
Table 79. LFB group Company Details
Table 80. LFB group Business Overview
Table 81. LFB group Primary Immunodeficiency Therapeutic Product
Table 82. LFB group Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 83. LFB group Recent Development
Table 84. Grifols Company Details
Table 85. Grifols Business Overview
Table 86. Grifols Primary Immunodeficiency Therapeutic Product
Table 87. Grifols Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 88. Grifols Recent Development
Table 89. Lupin Pharmaceuticals Company Details
Table 90. Lupin Pharmaceuticals Business Overview
Table 91. Lupin Pharmaceuticals Primary Immunodeficiency Therapeutic Product
Table 92. Lupin Pharmaceuticals Revenue in Primary Immunodeficiency Therapeutic Business (2020-2025) & (US$ Million)
Table 93. Lupin Pharmaceuticals Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Primary Immunodeficiency Therapeutic Picture
Figure 2. Global Primary Immunodeficiency Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Immunodeficiency Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Immunoglobulin Replacement Therapy Features
Figure 5. Stem Cell or Bone Marrow Transplantation Features
Figure 6. Antibiotic Therapy Features
Figure 7. Gene Therapy Features
Figure 8. Others Features
Figure 9. Global Primary Immunodeficiency Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Primary Immunodeficiency Therapeutic Market Share by Application: 2024 VS 2031
Figure 11. Antibody Deficiency Case Studies
Figure 12. Cellular Immunodeficiency Case Studies
Figure 13. Innate Immune Disorders Case Studies
Figure 14. Others Case Studies
Figure 15. Primary Immunodeficiency Therapeutic Report Years Considered
Figure 16. Global Primary Immunodeficiency Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Primary Immunodeficiency Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Primary Immunodeficiency Therapeutic Market Share by Region: 2024 VS 2031
Figure 19. Global Primary Immunodeficiency Therapeutic Market Share by Players in 2024
Figure 20. Global Top Primary Immunodeficiency Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Immunodeficiency Therapeutic as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Primary Immunodeficiency Therapeutic Revenue in 2024
Figure 22. North America Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Primary Immunodeficiency Therapeutic Market Share by Country (2020-2031)
Figure 24. United States Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Primary Immunodeficiency Therapeutic Market Share by Country (2020-2031)
Figure 28. Germany Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Primary Immunodeficiency Therapeutic Market Share by Region (2020-2031)
Figure 36. China Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Primary Immunodeficiency Therapeutic Market Share by Country (2020-2031)
Figure 44. Mexico Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Primary Immunodeficiency Therapeutic Market Share by Country (2020-2031)
Figure 48. Turkey Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Primary Immunodeficiency Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Baxter International Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 53. CSL Limited Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 54. Octapharma Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 55. Kedrion Biopharma Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 56. Bio Products Laboratory Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 57. LFB group Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 58. Grifols Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 59. Lupin Pharmaceuticals Revenue Growth Rate in Primary Immunodeficiency Therapeutic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
